2021
DOI: 10.1007/978-981-33-6044-0_1
|View full text |Cite
|
Sign up to set email alerts
|

Phenotype Network and Brain Structural Covariance Network of Major Depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 68 publications
0
8
1
Order By: Relevance
“…In the analysis of group-level SCN, we did not detect any significant differences in inter-group comparisons. Despite prior investigations indicating group-level differences in structural covariance aberrance (Chen et al, 2022a;Neufeld et al, 2020;Singh et al, 2013;Watanabe et al, 2020;Xiong et al, 2021;Yun & Kim, 2021), our current study did not reveal any significant differences between patients with MDD and HCs. The inconsistent findings across studies may be attributed to factors such as small sample sizes in previous single-center investigations, comorbidities, medication, age of onset (Han et al, 2021;Schmaal et al, 2017).…”
Section: Discussioncontrasting
confidence: 99%
“…In the analysis of group-level SCN, we did not detect any significant differences in inter-group comparisons. Despite prior investigations indicating group-level differences in structural covariance aberrance (Chen et al, 2022a;Neufeld et al, 2020;Singh et al, 2013;Watanabe et al, 2020;Xiong et al, 2021;Yun & Kim, 2021), our current study did not reveal any significant differences between patients with MDD and HCs. The inconsistent findings across studies may be attributed to factors such as small sample sizes in previous single-center investigations, comorbidities, medication, age of onset (Han et al, 2021;Schmaal et al, 2017).…”
Section: Discussioncontrasting
confidence: 99%
“…Combing with results that identified two subtypes shared indistinguishable duration of illness, sex, age and the total HAMD score, our results revealed that high morphological heterogeneity might be inherent to the pathophysiology of depression. Although abnormal structural covariance had been reported in previous studies, they exclusively obtained group-level differential structural covariance aberrance ignoring interindividual heterogeneity (Lee et al, 2019; Neufeld & Kaczkurkin, 2020; Watanabe et al, 2020; Yun & Kim, 2021). To our knowledge, the current study was the first attempt to investigate subject-level differential structural covariance edges in depression.…”
Section: Discussionmentioning
confidence: 99%
“…Traditional case-control designs often focus on group-level aberrance while ignore the interindividual heterogeneity (Wolfers et al, 2018). Although studies have revealed altered structural covariance in depression, most of them exclusively probe group-level aberrance (Mak, Colloby, Thomas, & O'Brien, 2016; Rashidi-Ranjbar et al, 2020; Yun & Kim, 2021). Depicting individualized structural differences helps us to discover neuroimaging substrates underlying symptoms and uncover more homogeneous subtypes in heterogeneous disorders (Ajnakina et al, 2021; Das et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, adults with comorbid depression are less likely to quit smoking after being diagnosed with acute coronary syndrome 36 . To date, few studies have examined the associations between health-promoting behaviors and depressive symptoms in patients with chronic disease 37 39 .…”
Section: Introductionmentioning
confidence: 99%